Insights from patients with Ulcerative Colitis on disease burden Findings from a real-world survey in Europe (ECCO 2022)

Gastro-enterologie

01/03 - Ulcerative colitis (UC) requires life-long management with symptom control and disease remission being the ultimate goals. Despite existing treatments (Tx), there are patients without fully controlled disease which impacts their health-related quality of life (HRQoL). The survey presented at the ECCO meeting 2022, investigated the disease burden, including residual disease symptoms and quality of life impairment, among moderate-severe UC patients in remission and not in remission.